Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 264-513-3 | CAS number: 63843-89-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Based on the available experimental data, the substance is taken up after ingestion and to a lesser extent by skin contact. The physico-chemical properties and the two ester functions indicate that there is little potential for bioaccumulation.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
Additional information
A specific toxicokinetic study is not available, but the subacute oral toxicity studies in rat show a rather specific hazard profile. It appears that the substance is taken up after ingestion because it causes adverse effects on mesenteric lymph nodes at lower doses and on spleen and liver at higher doses. It causes granulomatous inflammation of the intestinal tract which indicates uptake into the macrophages. As part of the micronucleus study in vivo, the substance was measured and detected in a total of six plasma samples taken from each three mice 1h and 4h after a single gavage dose of 2000 mg/kg bw (BASF 2015).
Regarding dermal absorption, little information is available. The molecular weight of > 500 and the n-octanol-water partition coefficient of > 4 are in the range for which low dermal absorption (10%) can be assumed (EU guidance document on dermal absorption, Sanco/222/2000 rev. 7, 19 March 2004). The substance is of moderate solubility in artificial perspiration fluid (16 mg/L, 37°C) and acute oral toxiciy is higher than acute dermal toxicity: LD 50 (oral) = 1490 mg/kg bw compared to absence of toxicity upon acute dermal expsoure at 3170 mg/kg bw.
In the study for skin sensitization, a skin reaction was observed for intradermal challenge, but not for the epidermal challenge (Ciba 1977). All indicators taken together, systemic availability by skin contact is possible but less good than by the oral route.
A 14 -day study with dermal exposure was performed in mice in order to investigate certain immunologic parameters. This study is of limited value to assess skin permeability as no precautions against preening was taken, and indeed it was recorded in the report that animals were licking the treated areas (abdomen). Under this regime, increase in spleen weight and changes in haematology were observed as for the oral route. As to the effective dose levels, a comparison is not possible because of the spacing and of the shorter duration. The 14 -day "dermal" route caused no effects on body weight and no mortality at dose levels, that were effective in rats at oral dosing. Considering that the effects were less severe and are at least in part due to oral exposure, this also indcates that skin permeability is lower than oral absorption.
Regarding systemic availability after inhalation, this needs to be assumed. The available acute inhalation study does not show adverse effects but was performed at a dose level about ten times lower than the limit dose.
Experimental data on reversibility on effects or metabolism is not available.
The substance contains two ester functions that are prone to enzymatic hydrolysis. It also contains a phenolic hydroxy group which is however sterically blocked by two teriary butyl groups and is therefore unlikely to become conjucated.
Ester hydrolysis products would be sufficently small for elimination via the kidney.
Other degradation products may be formed from oxidative destruction in macrophages.
Both the potential for enzymatic ester hydrolysis and the moderate solubility in water indicates that the substance does not have a significant potential for bioaccumulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.